Pimecrolimus
- Generic Name
- Pimecrolimus
- Brand Names
- Elidel
- Drug Type
- Small Molecule
- Chemical Formula
- C43H68ClNO11
- CAS Number
- 137071-32-0
- Unique Ingredient Identifier
- 7KYV510875
- Background
Pimecrolimus is an immunomodulating agent that was first marketed by Novartis under the trade name Elidel. It is now promoted in Canada by Galderma since early 2007. It is currently available as a topic cream used in the treatment of atopic dermatitis (eczema).
- Indication
For treatment of mild to moderate atopic dermatitis.
- Associated Conditions
- Vitiligo, Intertriginous psoriasis, Mild Atopic dermatitis, Moderate Atopic dermatitis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath